SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,217,462,122 |
| Positions | 24 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | SRRK | COM | $379,370,860 | 6,897,652 |
| ALUMIS INC | ALMS | COM | $178,554,463 | 6,345,219 |
| MINERALYS THERAPEUTICS INC | MLYS | COM | $158,400,066 | 5,871,018 |
| SEPTERNA INC | SEPN | COM | $105,464,297 | 3,149,128 |
| ALAMAR BIOSCIENCES INC | ALMR | COMMON STOCK | $67,191,598 | 2,480,310 |
| NEUROGENE INC | NGNE | COM | $54,003,644 | 1,717,127 |
| KALARIS THERAPEUTICS INC | KLRS | COM | $52,426,382 | 12,881,175 |
| SPYGLASS PHARMA INC | SGP | COM SHS | $46,967,554 | 2,109,953 |
| SUTRO BIOPHARMA INC | STRO | COM SHS | $35,287,350 | 1,062,872 |
| INVENTIVA SA | IVA | ADS | $23,869,963 | 6,314,805 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.